Table 3. Difference in change from baseline in metabolic and liver parameters for the maraviroc + OBT versus OBT group with bootstrapped 95% confidence intervals.
| Week | Number of participants | Difference between MVC+OBT / OBT groups in change from baseline | 95% LCL | 95% UCL | |
|---|---|---|---|---|---|
| BMI, kg/m2 | 48 | 45 | 0.1 | -0.7 | 0.8 |
| 96 | 45 | 0.1 | -0.5 | 0.7 | |
| Waist circumference, cm | 48 | 43 | 2.6 | -4.0 | 9.2 |
| 96 | 42 | 1.5 | -6.4 | 9.3 | |
| CD4 cell count, cells/mm3 | 48 | 45 | 70 | -39 | 179 |
| 96 | 44 | -47 | -133 | 39.4 | |
| Fasting glucose, mmol/L | 48 | 44 | 0.0 | -0.8 | 0.7 |
| 96 | 42 | 0.8 | -0.5 | 2.2 | |
| HbA1c, mmol/mol | 48 | 45 | -2.3 | -6.7 | 2.1 |
| 96 | 45 | 2.5 | -2.6 | 7.7 | |
| AST, U/L | 48 | 43 | -0.5 | -6.9 | 5.9 |
| 96 | 38 | 7.0 | -2.8 | 16.8 | |
| ALT, U/L | 48 | 44 | -5.7 | -21.1 | 9.7 |
| 96 | 45 | 0.5 | -19.8 | 20.7 | |
| Fasting triglycerides, mmol/L | 48 | 44 | 0.7 | 0.0 | 1.4 |
| 96 | 46 | -0.2 | -1.0 | 0.6 | |
| Fasting LDL, mmol/L | 48 | 40 | 0.0 | -0.4 | 0.4 |
| 96 | 41 | 0.0 | -0.4 | 0.5 | |
| Fasting HDL, mmol/L | 48 | 44 | 0.0 | -0.1 | 0.2 |
| 96 | 46 | 0.1 | -0.1 | 0.3 | |
| Fasting HDL: total chol. ratio | 48 | 44 | 0.3 | -0.6 | 1.1 |
| 96 | 46 | -0.3 | -1.0 | 0.4 | |
| Fasting total chol., mmol/L | 48 | 44 | 0.1 | -0.4 | 0.6 |
| 96 | 46 | 0.1 | -0.4 | 0.6 | |
| Fibroscan median LS, kPa | 48 | 43 | -1.7 | -3.7 | 0.4 |
| 96 | 41 | -0.6 | -2.4 | 1.2 | |
| Fibroscan CAP score, dB/m | 48 | 41 | -15.1 | -57.8 | 27.6 |
| 96 | 39 | -5.8 | -40.0 | 28.5 | |
| ELF score | 48 | 43 | 0.3 | 0.0 | 0.6 |
| 96 | 42 | 0.1 | -0.3 | 0.5 |
LCL, lower confidence limit; UCL upper confidence limit